Shenyang Xingqi Pharmaceutical Co.,Ltd

SZSE:300573.SZ

150.38 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Revenue 1,943.3881,467.571,249.8551,027.915688.682542.434431.205360.007339.1287.439254.653218.631212.326190.537
Cost of Revenue 421.113340.355265.672225.246185.029145.049119.35993.94284.10685.09262.55629.93225.54420.596
Gross Profit 1,522.2751,127.215984.183802.669503.653397.385311.846266.065254.994202.347192.097188.699186.783169.941
Gross Profit Ratio 0.7830.7680.7870.7810.7310.7330.7230.7390.7520.7040.7540.8630.880.892
Reseach & Development Expenses 208.675167.297145.61488.44763.19353.96740.96831.83719.58615.94710.2711.199.7240
General & Administrative Expenses 72.74173.70547.54739.15626.55221.82716.07817.30514.95613.72113.2278.89229.65430.019
Selling & Marketing Expenses 384.376243.779463.433338.271244.214219.283193.398133.83131.567110.47108.75399.481103.90993.458
SG&A 457.117670.906510.981377.428270.766241.11209.476151.136146.523124.191121.981108.373133.564123.476
Other Expenses 431.7330.10580.56686.79553.71255.386-0.357-0.31110.9964.71719.6243.412.8940.686
Operating Expenses 1,097.525858.989737.161552.669387.672350.462294.592215.159196.443166.328159.07135.82137.193126.811
Operating Income 424.751276.52250.103248.398105.73837.68811.52546.14653.49121.57818.0751.9485040.921
Operating Income Ratio 0.2190.1880.20.2420.1540.0690.0270.1280.1580.0750.0710.2380.2350.215
Total Other Income Expenses Net -29.719-11.5272.522-4.856-3.196-1.871-0.357-0.3116.401-7.44619.5313.4093.7690.686
Income Before Tax 395.031264.993233.718243.542102.54235.81711.16845.83564.48326.29537.60155.35852.89441.606
Income Before Tax Ratio 0.2030.1810.1870.2370.1490.0660.0260.1270.190.0910.1480.2530.2490.218
Income Tax Expense 56.9724.95722.03434.4349.0826.3062.167.39710.2044.3156.5919.2619.1915.97
Net Income 338.062240.036211.684194.70287.97935.89413.65939.43754.27921.9831.0146.09743.70335.637
Net Income Ratio 0.1740.1640.1690.1890.1280.0660.0320.110.160.0760.1220.2110.2060.187
EPS 1.941.381.711.580.780.320.170.490.90.370.520.770.730.59
EPS Diluted 1.931.381.711.580.770.320.170.490.90.370.520.770.730.59
EBITDA 503.245355.242315.5323.878157.84384.1250.08486.089109.9571.35258.82463.44650.05543.131
EBITDA Ratio 0.2590.2420.2520.3150.2290.1550.1160.2390.3240.2480.2310.290.2360.226